Table 2 Comparison of the initial colonoscopy conditions between the two groups
From: Effectiveness of switching endoscopists for repeat surveillance colonoscopy: a retrospective study
Outcomes | D group | S group | p value |
|---|---|---|---|
Number of patients (Total: 205) | 102 | 103 | |
High resolution scope, n (%) | 33 (32.4) | 35 (34.0) | 0.88 |
Performed by a trainee, n (%) | 15 (14.7) | 21 (20.4) | 0.36 |
BBPS ≥ 6, n (%) | 99 (97.1) | 95 (92.2) | 0.21 |
Withdrawal time > 6 min, n (%) | 96 (94.1) | 95 (92.2) | 0.78 |
Total withdrawal time, median (IQR) | 13.5 (10.4–17.4) | 13.6 (9.3–17.4) | 0.72 |
Midazolam usage, n (%) | 88 (86.2) | 96 (93.2) | 0.11 |
Pethidine hydrochloride usage, n (%) | 65 (63.7) | 54 (52.4) | 0.12 |
Antispasmodic usage, n (%) | 0.88 | ||
Scopolamine butylbromide | 63 (61.8) | 67 (65.1) | |
Glucagon | 33 (32.4) | 30 (29.1) | |
None | 6 (5.9) | 6 (5.8) | |
Polyps per colonoscopy (95%CI) | 4.15 (3.60–4.71) | 3.65 (3.10–4.19) | 0.15 |